PortalPublikationenInvolvement of the atrial natriuretic peptide transcription ...

Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.

Standard

Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. / Kiefer, F; Witt, S H; Frank, J; Richter, A; Treutlein, J; Lemenager, T; Nöthen, M M; Cichon, S; Batra, A; Berner, M; Wodarz, N; Zimmermann, U S; Spanagel, R; Wiedemann, Klaus; Smolka, M N; Heinz, A; Rietschel, M; Mann, K.

in: PHARMACOGENOMICS J, Jahrgang 11, Nr. 5, 5, 2011, S. 368-374.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Kiefer, F, Witt, SH, Frank, J, Richter, A, Treutlein, J, Lemenager, T, Nöthen, MM, Cichon, S, Batra, A, Berner, M, Wodarz, N, Zimmermann, US, Spanagel, R, Wiedemann, K, Smolka, MN, Heinz, A, Rietschel, M & Mann, K 2011, 'Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.', PHARMACOGENOMICS J, Jg. 11, Nr. 5, 5, S. 368-374. <http://www.ncbi.nlm.nih.gov/pubmed/20585342?dopt=Citation>

APA

Kiefer, F., Witt, S. H., Frank, J., Richter, A., Treutlein, J., Lemenager, T., Nöthen, M. M., Cichon, S., Batra, A., Berner, M., Wodarz, N., Zimmermann, U. S., Spanagel, R., Wiedemann, K., Smolka, M. N., Heinz, A., Rietschel, M., & Mann, K. (2011). Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. PHARMACOGENOMICS J, 11(5), 368-374. [5]. http://www.ncbi.nlm.nih.gov/pubmed/20585342?dopt=Citation

Vancouver

Kiefer F, Witt SH, Frank J, Richter A, Treutlein J, Lemenager T et al. Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate. PHARMACOGENOMICS J. 2011;11(5):368-374. 5.

Bibtex

@article{1ffe5a9b67fb4c198e159eda3ef6d818,
title = "Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.",
abstract = "In alcoholism, both relapse to alcohol drinking and treatment response are suggested to be genetically modulated. This study set out to determine whether the top 15 single nucleotide polymorphisms (SNPs) of a recent genome-wide association (GWA) and follow-up study of alcohol dependence are associated with relapse behavior and pharmacological treatment response in 374 alcohol-dependent subjects who underwent a randomized, double-blind, placebo-controlled trial with acamprosate, naltrexone or placebo. The single nucleotide polymorphism, rs13273672, an intronic SNP in the gene for GATA-binding protein 4 (GATA4), was associated with relapse within the 90-day medical treatment period (P",
author = "F Kiefer and Witt, {S H} and J Frank and A Richter and J Treutlein and T Lemenager and N{\"o}then, {M M} and S Cichon and A Batra and M Berner and N Wodarz and Zimmermann, {U S} and R Spanagel and Klaus Wiedemann and Smolka, {M N} and A Heinz and M Rietschel and K Mann",
year = "2011",
language = "Deutsch",
volume = "11",
pages = "368--374",
journal = "PHARMACOGENOMICS J",
issn = "1470-269X",
publisher = "NATURE PUBLISHING GROUP",
number = "5",

}

RIS

TY - JOUR

T1 - Involvement of the atrial natriuretic peptide transcription factor GATA4 in alcohol dependence, relapse risk and treatment response to acamprosate.

AU - Kiefer, F

AU - Witt, S H

AU - Frank, J

AU - Richter, A

AU - Treutlein, J

AU - Lemenager, T

AU - Nöthen, M M

AU - Cichon, S

AU - Batra, A

AU - Berner, M

AU - Wodarz, N

AU - Zimmermann, U S

AU - Spanagel, R

AU - Wiedemann, Klaus

AU - Smolka, M N

AU - Heinz, A

AU - Rietschel, M

AU - Mann, K

PY - 2011

Y1 - 2011

N2 - In alcoholism, both relapse to alcohol drinking and treatment response are suggested to be genetically modulated. This study set out to determine whether the top 15 single nucleotide polymorphisms (SNPs) of a recent genome-wide association (GWA) and follow-up study of alcohol dependence are associated with relapse behavior and pharmacological treatment response in 374 alcohol-dependent subjects who underwent a randomized, double-blind, placebo-controlled trial with acamprosate, naltrexone or placebo. The single nucleotide polymorphism, rs13273672, an intronic SNP in the gene for GATA-binding protein 4 (GATA4), was associated with relapse within the 90-day medical treatment period (P

AB - In alcoholism, both relapse to alcohol drinking and treatment response are suggested to be genetically modulated. This study set out to determine whether the top 15 single nucleotide polymorphisms (SNPs) of a recent genome-wide association (GWA) and follow-up study of alcohol dependence are associated with relapse behavior and pharmacological treatment response in 374 alcohol-dependent subjects who underwent a randomized, double-blind, placebo-controlled trial with acamprosate, naltrexone or placebo. The single nucleotide polymorphism, rs13273672, an intronic SNP in the gene for GATA-binding protein 4 (GATA4), was associated with relapse within the 90-day medical treatment period (P

M3 - SCORING: Zeitschriftenaufsatz

VL - 11

SP - 368

EP - 374

JO - PHARMACOGENOMICS J

JF - PHARMACOGENOMICS J

SN - 1470-269X

IS - 5

M1 - 5

ER -